OS09.7 Phase III radomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea

Introduction: Adoptive cell immunotherapy involves an ex vivo expansion of autologous cytokine-induced killer (CIK) cells before their reinfusion into the host. We evaluated the efficacy and safety of CIK cell immunotherapy with radiotherapy-temozolomide (TMZ) for the treatment of newly diagnosed gl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Kim, C., Nam, D., Kong, D., Kang, S., Jang, J., Kim, J., Lim, Y., Koh, Y., Chung, Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
ORAL PRESENTATIONS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463706/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.066
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller